|
With Biotechnology Companies Leading the Way, Six Venture-Backed IPOs Recorded in First Quarter
NEW YORK, N.Y., Apr 05, 2016 - (ACN Newswire) - Six venture-backed initial public offerings (IPOs) raised $574.5 million in the first quarter of 2016, according to the Exit Poll Report by Thomson Reuters and the National Venture Capital Association (NVCA). This marks the slowest quarter for venture-backed IPOs since the third quarter of 2011. By merger and acquisition (M&A), seventy-nine venture-backed M&A deals were reported in the first quarter, 20 of which reported an aggregate deal value of $4.8 billion.
"A strong IPO market requires a stable market for public stocks. Due to a sustained period of turbulence in the public markets at the start of the year combined with non-traditional investors making direct investments into later-stage startups, venture-backed IPO activity in the first quarter was nearly non-existent," said Bobby Franklin, President and CEO of NVCA. "Despite the successes of a handful of venture-backed biotechnology companies making IPOs, the IPO window for venture-backed companies from other sectors has been completely shut. While this may cause some to panic, venture capital is a long-game business and seasoned venture investors have lived through these slowdowns before. As they wait for the IPO window to open again, venture investors are keeping calm and carrying on, focusing their attention on growing and maintaining their portfolios of the next generation of great American companies."
Image1: https://www.acnnewswire.com/topimg/Low_TR1604051.jpg
IPO Activity Overview
There were six venture-backed IPOs valued at $574.5 million in the first quarter of 2016. By number of deals, quarterly volume fell 65 percent compared to the first quarter of 2015 and registered similar declines by dollars raised. The first quarter of 2016 marks the slowest quarter for venture-backed IPOs since the third quarter of 2011, when five companies raised $475.9 million.
Led by biotechnology companies, all six of this quarter's offerings were life sciences IPOs. The first quarter of 2016 marks the first time that no venture-backed technology companies listed publicly since the first quarter of 2009, which marked the second consecutive quarter without a U.S. venture-backed listing in any industry.
By location, five of the quarter's six IPOs were from U.S.-based companies. The largest U.S. offering of the quarter, Cambridge, Massachusetts-based Editas Medicine (EDIT) raised $108.6 million on the NASDAQ stock exchange on February 2nd.
In the largest IPO of the quarter, Beijing, China-based BeiGene Ltd (BGNE), raised $182.2 million and began trading on the NASDAQ stock exchange on February 2nd. At the end of the first quarter, the company traded 22 percent above its $24 offering price.
Image2: https://www.acnnewswire.com/topimg/Low_TR1604052.jpg
All six venture-backed companies listed on the NASDAQ stock exchange during the first quarter of 2016.
Five of the six companies brought to market in the first quarter are currently trading at or above their offering price. There are 43 venture-backed companies currently registered publicly for an IPO with the SEC. This figure does not include confidential registrations filed under the JOBS Act, where many observers believe the majority of venture-backed companies now file.
Mergers and Acquisitions Overview
As of March 31st, 79 venture-backed M&A deals were reported for the first quarter of 2016, 20 of which had an aggregate deal value of $4.8 billion, a 19 percent decline compared to the overall number of deals reported during the first quarter of 2015, but double the disclosed M&A value registered a year ago.
The information technology sector led the venture-backed M&A landscape with 57 of the 79 deals of the quarter and had a disclosed total dollar value of $3.8 billion. Within this sector, computer software and services and internet specific deals accounted for the bulk of the targets with 33 and 12 transactions, respectively.
Image3: https://www.acnnewswire.com/topimg/Low_TR1604053.jpg
The largest venture-backed M&A transaction during the first quarter of 2016 was Cisco System's $1.4 billion acquisition of Mountain View, California-based Jasper Technologies, followed by NetApp Inc's $870.0 million purchase of Solidfire, Inc, a Boulder, Colorado-based provider of data storage systems. France's Thales SA acquired San-Jose, California-based Vormetric Inc for $400 million, which ranked as the third largest venture-backed M&A deal during the quarter.
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges (symbol: TRI). For more information, go to www.thomsonreuters.com.
About National Venture Capital Association
Venture capitalists are committed to funding America's most innovative entrepreneurs, working closely with them to transform breakthrough ideas into emerging growth companies that drive U.S. job creation and economic growth. As the voice of the U.S. venture capital community, the National Venture Capital Association (NVCA) empowers its members and the entrepreneurs they fund by advocating for policies that encourage innovation and reward long-term investment. As the venture community's preeminent trade association, the NVCA serves as the definitive resource for venture capital data and unites its over 300 member firms through a full range of professional services. For more information about the NVCA, please visit www.nvca.org.
CONTACTS
Ben Veghte NVCA +1-202-864-5923 bveghte@nvca.org
Ilya Hemlin Thomson Reuters +1-646-223-5532 ilya.hemlin@thomsonreuters.com
###
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Thomson Reuters Corporation via Globenewswire
Source: Thomson Reuters
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Press Release
 HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion Dec 12, 2025 23:15 JST
|  Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition Dec 12, 2025 11:00 JST
|  MHI and Worley to Deliver Full-Scale Carbon Capture Facility for Heidelberg Materials UK's Padeswood Cement Works Dec 08, 2025 17:00 JST
|  Honda Technical Support for Red Bull Powertrains in F1 Racing Concludes Dec 08, 2025 16:34 JST
|  MHIET U.S. Subsidiary's Franklin Plant Celebrates 10th Anniversary Dec 08, 2025 16:03 JST
|  Lexus World Premieres Lexus LFA Concept BEV Sports Car Dec 05, 2025 19:13 JST
|  TOYOTA GAZOO Racing World Premieres GR GT & GR GT3 Dec 05, 2025 18:58 JST
|  TOYOTA GAZOO Racing and Lexus Hold World Premiere of GR GT, GR GT3, and Lexus LFA Concept Dec 05, 2025 18:24 JST
|  World's First General Design Approval (GDA) for Developed Steel and Post-Weld Heat Treatment (PWHT) Exemption based on ECA for Low-pressure Liquefied CO2 Tank made of KF460 steel Dec 05, 2025 18:17 JST
|  Hitachi at CES 2026: Building a Harmonized Society Through Technology Dec 04, 2025 19:40 JST
|  Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference Dec 04, 2025 19:08 JST
|  NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration Dec 04, 2025 18:52 JST
|  Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at CTAD 2025 Dec 04, 2025 18:36 JST
|  The 26th Hong Kong Forum marks successful completion Dec 03, 2025 22:44 JST
|  New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF Dec 03, 2025 18:19 JST
|  Mitsubishi Motors Launches the All-New Destinator in Vietnam Dec 03, 2025 18:00 JST
|  Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15 Dec 03, 2025 11:30 JST
|  Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025 Dec 03, 2025 00:01 JST
|  NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI Dec 02, 2025 23:43 JST
|  Fujitsu develops new technology to support human-robot collaboration Dec 02, 2025 23:26 JST
|
More Latest Release >>
|